|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jin Y, Lu J, Wen J, Shen Y and Wen X:
Regulation of growth of human bladder cancer by miR-192. Tumour
Biol. 36:3791–3797. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Berry WL and Janknecht R: KDM4/JMJD2
histone demethylases: Epigenetic regulators in cancer cells. Cancer
Res. 73:2936–2942. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gray SG, Iglesias AH, Lizcano F,
Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW,
Kokkotou E and Dangond F: Functional characterization of JMJD2A, a
histone deacetylase- and retinoblastoma-binding protein. J Biol
Chem. 280:28507–28518. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang D, Yoon HG and Wong J: JMJD2A is a
novel N-CoR-interacting protein and is involved in repression of
the human transcription factor achaete scute-like homologue 2
(ASCL2/Hash2). Mol Cell Biol. 25:6404–6414. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li BX, Zhang MC, Luo CL, Yang P, Li H, Xu
HM, Xu HF, Shen YW, Xue AM and Zhao ZQ: Effects of RNA
interference-mediated gene silencing of JMJD2A on human breast
cancer cell line MDA-MB-231 in vitro. J Exp Clin Cancer Res.
30:902011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berry WL, Shin S, Lightfoot SA and
Janknecht R: Oncogenic features of the JMJD2A histone demethylase
in breast cancer. Int J Oncol. 41:1701–1706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kauffman EC, Robinson BD, Downes MJ,
Powell LG, Lee MM, Scherr DS, Gudas LJ and Mongan NP: Role of
androgen receptor and associated lysine-demethylase coregulators,
LSD1 and JMJD2A, in localized and advanced human bladder cancer.
Mol Carcinog. 50:931–944. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kogure M, Takawa M, Cho HS, Toyokawa G,
Hayashi K, Tsunoda T, Kobayashi T, Daigo Y, Sugiyama M, Atomi Y, et
al: Deregulation of the histone demethylase JMJD2A is involved in
human carcinogenesis through regulation of the G(1)/S transition.
Cancer Lett. 336:76–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mallette FA and Richard S: JMJD2A promotes
cellular transformation by blocking cellular senescence through
transcriptional repression of the tumor suppressor CHD5. Cell Rep.
2:1233–1243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim TD, Shin S, Berry WL, Oh S and
Janknecht R: The JMJD2A demethylase regulates apoptosis and
proliferation in colon cancer cells. J Cell Biochem. 113:1368–1376.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bryan RT: Cell adhesion and urothelial
bladder cancer: The role of cadherin switching and related
phenomena. Philos Trans R Soc Lond B Biol Sci. 370:201400422015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Muramaki M, Miyake H, Terakawa T, Kumano
M, Sakai I and Fujisawa M: Expression profile of E-cadherin and
N-cadherin in non-muscle-invasive bladder cancer as a novel
predictor of intravesical recurrence following transurethral
resection. Urol Oncol. 30:161–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han B, Cui D, Jing Y, Hong Y and Xia S:
Estrogen receptor β (ERβ) is a novel prognostic marker of
recurrence survival in non-muscle-invasive bladder cancer
potentially by inhibiting cadherin switch. World J Urol.
32:149–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhi Y, Pan J, Shen W, He P, Zheng J, Zhou
X, Lu G, Chen Z and Zhou Z: Ginkgolide B inhibits human bladder
cancer cell migration and invasion through microRNA-223-3p. Cell
Physiol Biochem. 39:1787–1794. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wan J, Zhan J, Li S, Ma J, Xu W, Liu C,
Xue X, Xie Y, Fang W, Chin YE and Zhang H: PCAF-primed EZH2
acetylation regulates its stability and promotes lung
adenocarcinoma progression. Nucleic Acids Res. 43:3591–3604. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role
of epithelial-to-mesenchymal transition (EMT) in drug sensitivity
and metastasis in bladder cancer. Cancer Metastasis Rev.
28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yun SJ and Kim WJ: Role of the
epithelial-mesenchymal transition in bladder cancer: From prognosis
to therapeutic target. Korean J Urol. 54:645–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
